Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 41.03% | 979.17% | 5.56% | -- | 212.00% |
| Total Other Revenue | -- | 0.00% | 200.00% | -- | -- |
| Total Revenue | 41.03% | 940.00% | 17.65% | -- | 212.00% |
| Cost of Revenue | -11.48% | -3.59% | -4.94% | 9.26% | 28.29% |
| Gross Profit | 16.00% | 27.04% | 5.44% | -15.51% | -22.10% |
| SG&A Expenses | 72.40% | 28.13% | 43.05% | 38.28% | 13.32% |
| Depreciation & Amortization | 38.11% | 30.66% | 31.02% | 23.77% | 9.24% |
| Other Operating Expenses | 1.48% | -164.15% | 46.05% | -353.56% | 11.35% |
| Total Operating Expenses | 72.86% | 27.49% | 9.72% | 26.73% | 50.07% |
| Operating Income | -72.93% | -26.93% | -9.71% | -26.90% | -49.92% |
| Income Before Tax | -70.27% | -50.66% | 0.97% | -18.55% | -44.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.27% | -50.66% | 0.97% | -18.55% | -44.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.27% | -50.66% | 0.97% | -18.55% | -44.59% |
| EBIT | -72.93% | -26.93% | -9.71% | -26.90% | -49.92% |
| EBITDA | -74.60% | -26.79% | -9.29% | -27.01% | -51.55% |
| EPS Basic | -29.01% | -11.90% | 28.21% | -8.23% | -31.88% |
| Normalized Basic EPS | -28.86% | 7.94% | -1.43% | -7.41% | -32.26% |
| EPS Diluted | -29.01% | -11.90% | 28.21% | -8.23% | -31.88% |
| Normalized Diluted EPS | -28.86% | 7.94% | -1.43% | -7.41% | -32.26% |
| Average Basic Shares Outstanding | 32.10% | 34.39% | 37.88% | 9.62% | 9.63% |
| Average Diluted Shares Outstanding | 32.10% | 34.39% | 37.88% | 9.62% | 9.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |